Unlock stock picks and a broker-level newsfeed that powers Wall Street.
41.95
+3.31
+(8.57%)
At close: 4:00:00 PM EDT
40.94
-1.01
(-2.41%)
After hours: 4:30:30 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 7 | 8 |
| Avg. Estimate | -0.99 | -1 | -4.05 | -4.53 |
| Low Estimate | -1.09 | -1.05 | -4.31 | -4.94 |
| High Estimate | -0.94 | -0.94 | -3.76 | -4 |
| Year Ago EPS | -0.9 | -0.81 | -3.75 | -4.05 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.93 | -0.89 | -0.93 | -1.12 |
| EPS Actual | -0.9 | -0.81 | -1.05 | -0.99 |
| Difference | 0.03 | 0.08 | -0.12 | 0.13 |
| Surprise % | 2.83% | 8.80% | -12.36% | 11.83% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.99 | -1 | -4.05 | -4.53 |
| 7 Days Ago | -1.05 | -1.07 | -4.23 | -4.66 |
| 30 Days Ago | -1.11 | -1.11 | -4.84 | -4.94 |
| 60 Days Ago | -1.14 | -1.1 | -4.79 | -4.6 |
| 90 Days Ago | -1.14 | -1.1 | -4.87 | -4.67 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 4 | 2 | 3 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AKRO | -10.18% | -23.93% | -7.97% | -11.81% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
| Maintains | UBS: Buy to Buy | 1/31/2025 |
| Upgrade | B of A Securities: Neutral to Buy | 1/30/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/16/2025 |
| Initiated | Citigroup: Buy | 11/18/2024 |
Related Tickers
ETNB 89bio, Inc.
7.19
+5.81%
MDGL Madrigal Pharmaceuticals, Inc.
334.60
+3.28%
SRRK Scholar Rock Holding Corporation
32.54
+8.25%
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
PTGX Protagonist Therapeutics, Inc.
48.20
+2.82%
MLTX MoonLake Immunotherapeutics
38.05
+4.68%
RNA Avidity Biosciences, Inc.
29.77
+11.33%
CRNX Crinetics Pharmaceuticals, Inc.
31.39
+2.51%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
ACLX Arcellx, Inc.
67.23
+10.76%